Acinetobacter baumannii: an evolving and cunning opponent
J Shi, J Cheng, S Liu, Y Zhu, M Zhu - Frontiers in Microbiology, 2024 - frontiersin.org
Acinetobacter baumannii is one of the most common multidrug-resistant pathogens causing
nosocomial infections. The prevalence of multidrug-resistant A. baumannii infections is …
nosocomial infections. The prevalence of multidrug-resistant A. baumannii infections is …
Chromosomally encoded and plasmid-mediated polymyxins resistance in Acinetobacter baumannii: a huge public health threat
WG Lima, MC Alves, WS Cruz, MC Paiva - European journal of clinical …, 2018 - Springer
Acinetobacter baumannii is an opportunistic pathogen associated with nosocomial and
community infections of great clinical relevance. Its ability to rapidly develop resistance to …
community infections of great clinical relevance. Its ability to rapidly develop resistance to …
[HTML][HTML] First report of colistin resistance among carbapenem-resistant Acinetobacter baumannii isolates recovered from hospitalized patients in Egypt
Acinetobacter baumannii is an opportunistic pathogen that poses an increasing threat in the
health-care community. Colistin is one of the promising options for treatment of multidrug …
health-care community. Colistin is one of the promising options for treatment of multidrug …
The small molecule IITR08027 restores the antibacterial activity of fluoroquinolones against multidrug-resistant Acinetobacter baumannii by efflux inhibition
Efflux pumps are one of the major determinants of multiple drug resistance. In this study,
AbeM, a multidrug efflux pump in Acinetobacter baumannii, was cloned into a multicopy …
AbeM, a multidrug efflux pump in Acinetobacter baumannii, was cloned into a multicopy …
Glycyrrhetinic acid protects against Multidrug-resistant Acinetobacter baumannii-induced lung epithelial cells injury by regulating inflammation and oxidative stress
P Guo, L **, H Zhou, Y Bao, J Yang, J Chen… - BMC Pharmacology and …, 2023 - Springer
Glycyrrhetinic acid (GA) is a bio-effective component of Licorice. The GA is a monomer and
the ingredient is an Oleanane-type pentacyclic triterpenes that has been used as a remedy …
the ingredient is an Oleanane-type pentacyclic triterpenes that has been used as a remedy …
[HTML][HTML] Efflux pump inhibitor phenylalanine-arginine Β-naphthylamide effect on the minimum inhibitory concentration of imipenem in Acinetobacter baumannii strains …
Background: Acinetobacter baumannii has emerged as a highly troublesome pathogen and
a leading cause of mortality and morbidity among hospitalized burn patients. Objectives: The …
a leading cause of mortality and morbidity among hospitalized burn patients. Objectives: The …
Subinhibitory Concentrations of Clinically-Relevant Antimicrobials Affect Resistance-Nodulation-Division Family Promoter Activity in Acinetobacter baumannii
S Prieto Martin Gil, A Tajuelo, M López-Siles… - Frontiers in …, 2021 - frontiersin.org
Efflux pumps contribute to multidrug resistance in Acinetobacter baumannii due to their
ability to expel a wide variety of structurally unrelated compounds. This study aimed to …
ability to expel a wide variety of structurally unrelated compounds. This study aimed to …
Effect of Inhibitor Carbonyl Cyanide 3-Chlorophenylhydrazone (CCCP) on the Minimum Inhibitory Concentration of Aminoglycoside and efflux pump activity …
S Honarmand Jahromy, J Fathi Rad… - Iranian Journal of …, 2018 - zisti.varamin.iau.ir
Acietobacter baumanni is an important cause of nosocomial infections. This bacterium is
resistant to many commonly-used antibiotics and multidrug resistance is often responsible …
resistant to many commonly-used antibiotics and multidrug resistance is often responsible …
Acinetobacter baumannii as a causative agent of health care associated infections
MÁA Navarrete, RP y Terrón - GSC Biological and …, 2020 - gsconlinepress.com
Acinetobacter baumannii is an opportunistic pathogen that seriously affects sick patients,
causing Health Care Associated Infections (HCAI) such as pneumonia associated with …
causing Health Care Associated Infections (HCAI) such as pneumonia associated with …
[PDF][PDF] Acinetobacter Baumannii Endophthalmitis Following Intravitreal Ranibizumab Injection.
C ÇANKAYA, T CUMURCU… - Retina-Vitreus/Journal …, 2013 - retinavitreousjournal.com
We aimed to report a case who developed Acitenobacter baumannii endophthalmitis after
intravitreal Ranibizumab (Lucentis®) injection. A 79-year-old male patient was admitted with …
intravitreal Ranibizumab (Lucentis®) injection. A 79-year-old male patient was admitted with …